Skip to Main Content

Paper Details

A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer.
Mol Cancer Ther
3
2022
Author NameAffiliation
Jianmin WangRoswell Park Comprehensive Cancer Center
  • 1 - 1

Datasets

Release 1.2